glp-1 pancreatitis lawsuit in louisiana class action GLP-1 Agonists and Pancreatitis Risk: Reassessing an Old Concern with New Evidence louisiana semaglutide pancreatitis class action

It should be reapplied every 2-4 hours.

Contains Xylitol, do not feed to pets

, ,

Addressing current challenges will help translate promising findings into effective, personalized treatments

FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L

If the models prove successful, expect other manufacturers to follow them down this newly carved path